Kimberlee Caple
Director/Board Member bij CASTLE BIOSCIENCES, INC.
Vermogen: 104 216 $ op 31-03-2024
Profiel
Kimberlee S.
Caple is an Independent Director at Castle Biosciences, Inc. and Vice President & GM-Genetic Science Business at Thermo Fisher Scientific, Inc. She previously held positions as VP & GM-Molecular Diagnostics Business Unit at Life Technologies, Inc., Principal at Abbott Diagnostics, Inc., Vice President-Marketing & Business Development at Auxogyn, Inc., and Senior Vice President & GM-Clinical Business at Affymetrix, Inc. She completed her undergraduate degree at Purdue University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0.02% | 14-07-2023 | 4 705 ( 0.02% ) | 104 216 $ | 31-03-2024 |
Actieve functies van Kimberlee Caple
Bedrijven | Functie | Begin |
---|---|---|
CASTLE BIOSCIENCES, INC. | Director/Board Member | 16-07-2021 |
THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01-01-2020 |
Eerdere bekende functies van Kimberlee Caple
Bedrijven | Functie | Einde |
---|---|---|
AFFYMETRIX, INC. | Corporate Officer/Principal | 01-01-2016 |
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | - |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Opleiding van Kimberlee Caple
Purdue University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CASTLE BIOSCIENCES, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |